Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - ARATANA THERAPEUTICS, INC. | petx-20151231xex322.htm |
| EX-31.2 - EX-31.2 - ARATANA THERAPEUTICS, INC. | petx-20151231xex312.htm |
| EX-21.1 - EX-21.1 - ARATANA THERAPEUTICS, INC. | petx-20151231xex211.htm |
| EX-31.1 - EX-31.1 - ARATANA THERAPEUTICS, INC. | petx-20151231xex311.htm |
| EX-32.1 - EX-32.1 - ARATANA THERAPEUTICS, INC. | petx-20151231xex321.htm |
| EX-10.11 - EX-10.11 - ARATANA THERAPEUTICS, INC. | petx-20151231ex10116a054.htm |
| XML - IDEA: XBRL DOCUMENT - ARATANA THERAPEUTICS, INC. | R9999.htm |
| 10-K - 10-K - ARATANA THERAPEUTICS, INC. | petx-20151231x10k.htm |
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333- 189687, File Nos. 333- 193472 and 333- 203003) and the Registration Statement on Form S-3 (File No. 333-197414) of Aratana Therapeutics, Inc. of our report dated March 15, 2016 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 15, 2016